Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$8.12 - $10.63 $15.8 Million - $20.7 Million
1,950,500 Added 82.82%
4,305,674 $45 Million
Q3 2023

Oct 30, 2023

SELL
$7.48 - $10.7 $10.6 Million - $15.2 Million
-1,420,000 Reduced 37.61%
2,355,174 $24 Million
Q2 2023

Jul 24, 2023

BUY
$7.2 - $9.47 $6.4 Million - $8.42 Million
889,432 Added 30.82%
3,775,174 $28.4 Million
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $1.84 Million - $2.51 Million
220,384 Added 8.27%
2,885,742 $25.5 Million
Q4 2022

Feb 06, 2023

SELL
$7.95 - $9.48 $95,400 - $113,760
-12,000 Reduced 0.45%
2,665,358 $24.3 Million
Q3 2022

Oct 31, 2022

BUY
$6.86 - $11.95 $10.1 Million - $17.6 Million
1,474,889 Added 122.66%
2,677,358 $20.9 Million
Q2 2022

Aug 01, 2022

BUY
$7.38 - $10.4 $22,140 - $31,200
3,000 Added 0.25%
1,202,469 $9.01 Million
Q1 2022

May 09, 2022

BUY
$7.33 - $9.39 $5.01 Million - $6.42 Million
683,969 Added 132.68%
1,199,469 $11.2 Million
Q4 2021

Feb 08, 2022

SELL
$7.9 - $10.19 $5.17 Million - $6.66 Million
-654,044 Reduced 55.92%
515,500 $4.13 Million
Q3 2021

Nov 03, 2021

BUY
$8.38 - $10.18 $3.43 Million - $4.16 Million
409,128 Added 53.8%
1,169,544 $11.4 Million
Q2 2021

Aug 05, 2021

BUY
$9.9 - $11.56 $869,606 - $1.02 Million
87,839 Added 13.06%
760,416 $7.53 Million
Q1 2021

May 06, 2021

BUY
$10.34 - $12.81 $248,335 - $307,657
24,017 Added 3.7%
672,577 $7.76 Million
Q4 2020

Feb 02, 2021

BUY
$8.61 - $11.04 $66,297 - $85,008
7,700 Added 1.2%
648,560 $6.26 Million
Q3 2020

Nov 05, 2020

BUY
$8.57 - $12.69 $1.26 Million - $1.87 Million
147,167 Added 29.81%
640,860 $5.77 Million
Q2 2020

Aug 10, 2020

BUY
$8.12 - $13.12 $1.42 Million - $2.3 Million
175,469 Added 55.14%
493,693 $6.08 Million
Q1 2020

May 11, 2020

BUY
$6.69 - $13.45 $2.06 Million - $4.14 Million
307,924 Added 2989.55%
318,224 $2.84 Million
Q4 2019

Feb 10, 2020

SELL
$6.53 - $10.72 $6,530 - $10,720
-1,000 Reduced 8.85%
10,300 $100,000
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $2.06 Million - $3.21 Million
-334,394 Reduced 96.73%
11,300 $79,000
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $40,835 - $79,055
-5,029 Reduced 1.43%
345,694 $3.19 Million
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $1.32 Million - $1.69 Million
-84,413 Reduced 19.4%
350,723 $5.5 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $5.08 Million - $8.29 Million
347,866 Added 398.61%
435,136 $6.71 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $996,285 - $1.21 Million
47,307 Added 118.38%
87,270 $1.87 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $1.56 Million - $2.29 Million
-92,841 Reduced 69.91%
39,963 $956,000
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $2.2 Million - $2.91 Million
-131,907 Reduced 49.83%
132,804 $2.27 Million
Q4 2017

Feb 15, 2018

BUY
$11.23 - $19.1 $2.97 Million - $5.06 Million
264,711
264,711 $5.02 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Meitav Dash Investments LTD Portfolio

Follow Meitav Dash Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.